Total Payments
$35,722
2022 Payments
$530.00
Companies
5
Transactions
31
Payment Breakdown by Category
Other$16,843 (47.1%)
Consulting$16,356 (45.8%)
Travel$1,804 (5.1%)
Food & Beverage$719.44 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,356 | 6 | 45.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,913 | 12 | 38.9% |
| Honoraria | $2,400 | 1 | 6.7% |
| Travel and Lodging | $1,804 | 4 | 5.1% |
| Food and Beverage | $719.44 | 7 | 2.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $530.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Global Blood Therapeutics, Inc. | $28,546 | 21 | $0 (2022) |
| Emmaus Medical, Inc. | $2,500 | 1 | $0 (2020) |
| Omeros Corporation | $2,400 | 1 | $0 (2020) |
| Genentech, Inc. | $1,143 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,132 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $530.00 | 1 | Global Blood Therapeutics, Inc. ($530.00) |
| 2021 | $11,776 | 8 | Global Blood Therapeutics, Inc. ($11,776) |
| 2020 | $21,141 | 14 | Global Blood Therapeutics, Inc. ($16,241) |
| 2019 | $2,276 | 8 | Genentech, Inc. ($1,143) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/06/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $530.00 | General |
| Category: Sickle Cell Disease | ||||||
| 12/11/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $116.06 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 12/02/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,060.00 | General |
| 06/30/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $6,890.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/30/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/24/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $67.14 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 03/19/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $397.50 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/17/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $530.00 | General |
| 02/13/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,650.00 | General |
| 12/31/2020 | Emmaus Medical, Inc. | Endari (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Sickle Cell | ||||||
| 12/09/2020 | Omeros Corporation | Narsoplimab (Drug) | Honoraria | Cash or cash equivalent | $2,400.00 | General |
| Category: Hematology Oncology | ||||||
| 11/24/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $795.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/17/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,060.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/12/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $795.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/04/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,120.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/04/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,060.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 09/16/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,120.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 09/03/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,060.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 09/03/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,060.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/05/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,930.71 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/18/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,060.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/17/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,060.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/16/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,120.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 07/19/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | In-kind items and services | $297.39 | General |
| Category: HEMATOLOGY | ||||||
| 07/19/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $134.97 | General |
| Category: HEMATOLOGY | ||||||
About Dr. Jeremie Estepp, MD
Dr. Jeremie Estepp, MD is a Pediatrics healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1538360060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeremie Estepp, MD has received a total of $35,722 in payments from pharmaceutical and medical device companies, with $530.00 received in 2022. These payments were reported across 31 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($16,356).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Hematology-Oncology
- Location Memphis, TN
- Active Since 05/31/2007
- Last Updated 07/16/2018
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1538360060
Products in Payments
- OXBRYTA (Drug) $24,306
- Endari (Drug) $2,500
- Narsoplimab (Drug) $2,400
- ADAKVEO (Biological) $682.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Memphis
Richard Finkel, Md, MD
Pediatrics — Payments: $355,866
Pediatrics $355,866
Ugochi Ogu, M.d, M.D
Pediatrics — Payments: $218,361
Pediatrics $218,361
Maria Mejias, Md, MD
Pediatrics — Payments: $202,906
Pediatrics $202,906
Dr. Mark Weems, M.d, M.D
Pediatrics — Payments: $142,573
Pediatrics $142,573
Dr. Jason Johnson, M.d, M.D
Pediatrics — Payments: $131,258
Pediatrics $131,258
Dr. James Carter, M.d, M.D
Pediatrics — Payments: $88,126
Pediatrics $88,126